Company Overview of Nabi Biopharmaceuticals Inc.
As of October 30, 2012, Nabi Biopharmaceuticals Inc. was acquired by Biota Pharmaceuticals, Inc., in a reverse merger transaction. Nabi Biopharmaceuticals Inc. develops vaccines for unmet medical needs including nicotine addiction. The company develops NicVAX, a proprietary investigational vaccine for the treatment of nicotine addiction and prevention of smoking relapse based on patented technology. The company was formerly known as North American Biologicals, Inc. and changed its name to Nabi Biopharmaceuticals Inc. in 1996. Nabi Biopharmaceuticals Inc. was founded in 1967 and is headquartered in Rockville, Maryland.
12276 Wilkins Avenue
Rockville, MD 20852
Founded in 1967
Key Executives for Nabi Biopharmaceuticals Inc.
Nabi Biopharmaceuticals Inc. does not have any Key Executives recorded.
Similar Private Companies By Industry
|20n Labs, Inc.||United States|
|23andMe, Inc.||United States|
|2C Tech Corporation, Inc.||United States|
|3-V Biosciences, Inc.||United States|
|3D Bio Holdings LLC||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|Bloomberg L.P.||United States|
|NYC2012, Inc.||United States|
|The Advertising Council, Inc.||United States|
Sponsored Financial Commentaries
To contact Nabi Biopharmaceuticals Inc., please visit --. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.